Patterns and Prognosis of Local Recurrence of Nasopharyngeal Carcinoma after Intensity-modulated Radiotherapy

被引:2
作者
Xiao, Xiao-Tang [1 ]
Zou, Shi-Qian [1 ]
Chen, Yu-Pei [1 ]
Guo, Rui [1 ]
Tang, Ling-Long [1 ]
Sun, Ying [1 ]
Ma, Jun [1 ]
Li, Wen-Fei [1 ]
机构
[1] Sun Yat Sen Univ, State Key Lab Oncol South China, Guangdong Key Lab Nasopharyngeal Carcinoma Diag &, Canc Ctr, Guangzhou 510060, Peoples R China
基金
中国国家自然科学基金;
关键词
nasopharyngeal carcinoma; local recurrence; failure pattern; prognosis; IMRT;
D O I
10.7150/jca.88148
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: To investigate the patterns of local failure and prognosis in patients with locally recurrent nasopharyngeal carcinoma (rNPC) after primary intensity-modulated radiotherapy (IMRT). Methods: The data of 298 patients with locally rNPC after IMRT were retrospectively analyzed. Magnetic resonance images of the initial and recurrent tumors were reviewed and, for patients with extra-nasopharyngeal local recurrence, the gross tumor volume of local recurrence was transferred to the original IMRT plan for dosimetry analysis. Significant prognostic factors for overall survival (OS) were selected by multivariate Cox regression analysis. Results: The commonest recurrence sites were the nasopharynx (93%, 277/298) and skull base (53.7%, 160/298). Of the 21 patients with extra-nasopharyngeal recurrence (19 cases valid), 12 had in-field failures, 4 had marginal failures, and 3 had out-field failures. The ethmoid sinus (57.1%, 4/7) and nasal cavity (28.6%, 2/7) were the most frequent sites of marginal and out-field failures. After median follow-up of 37 months, the 3-year and estimated 5-year OS rates were 57.3% and 41.7%, respectively. Multivariate analysis showed that age, recurrence interval, plasma Epstein-Barr virus (EBV) DNA level, and recurrent T stage were independent prognostic factors for OS. Conclusions: Local failure after IMRT occurs most commonly in the nasopharynx and skull base. In patients with extra-nasopharyngeal recurrence, in-field failure remains the main failure pattern, and marginal and out-field failures mainly occur in the ethmoid sinus and nasal cavity. Elder age, shorter recurrence interval, detectable plasma EBV DNA, and advanced recurrent T stage are negative predictors of OS in patients with rNPC.
引用
收藏
页码:456 / 465
页数:10
相关论文
共 50 条
[41]   Efficacy and safety of intensity-modulated radiotherapy alone versus intensity-modulated radiotherapy plus chemotherapy for treatment of intermediate-risk nasopharyngeal carcinoma [J].
Aftab, Omer ;
Liao, Shufang ;
Zhang, Rongjun ;
Tang, Nan ;
Luo, Meiqing ;
Zhang, Bin ;
Shahi, Sanjeev ;
Rai, Raju ;
Ali, Jazib ;
Jiang, Wei .
RADIATION ONCOLOGY, 2020, 15 (01)
[42]   Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma [J].
Orlandi, Ester ;
Tomatis, Stefano ;
Potepan, Paolo ;
Bossi, Paolo ;
Mongioj, Valeria ;
Carrara, Mauro ;
Palazzi, Mauro ;
Franceschini, Marzia ;
Bergamini, Cristiana ;
Locati, Laura ;
Iannacone, Eva ;
Guzzo, Marco ;
Ibba, Tullio ;
Crippa, Flavio ;
Licitra, Lisa ;
Pignoli, Emanuele ;
Fallai, Carlo .
FUTURE ONCOLOGY, 2013, 9 (01) :103-114
[43]   Predictors for improvement of xerostomia in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy [J].
Pan, Xin-Bin ;
Liu, Yang ;
Huang, Shi-Ting ;
Chen, Kai-Hua ;
Jiang, Yan-Ming ;
Zhu, Xiao-Dong .
MEDICINE, 2019, 98 (36)
[44]   Prognostic Value and Staging Classification of Lymph Nodal Necrosis in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy [J].
Feng, Yanru ;
Cao, Caineng ;
Hu, Qiaoying ;
Chen, Xiaozhong .
CANCER RESEARCH AND TREATMENT, 2019, 51 (03) :1222-1230
[45]   The efficacy and toxicity of individualized intensity-modulated radiotherapy based on the tumor extension patterns of nasopharyngeal carcinoma [J].
Lin, Li ;
Yao, Ji-Jin ;
Zhou, Guan-Qun ;
Guo, Rui ;
Zhang, Fan ;
Zhang, Yuan ;
Xu, Lin ;
Zhang, Lu-Lu ;
Lin, Ai-Hua ;
Ma, Jun ;
Sun, Ying .
ONCOTARGET, 2016, 7 (15) :20680-20690
[46]   Intensity-modulated radiotherapy alone compared with intensity-modulated radiotherapy plus concurrent chemotherapy in intermediate-risk nasopharyngeal carcinoma [J].
Liao, Shufang ;
Zhang, Bin ;
Su, Yixin ;
Pan, Yufei ;
Zhang, Jian ;
Ye, Zhenkai ;
Zhang, Rongjun ;
Kong, Xiangyun ;
Qin, Guanjie ;
Mo, Yunyan ;
Ruan, Xiaolan ;
Liu, Jian ;
Gan, Chunqiao ;
Dai, Jinxuan ;
Zhang, Ruyun ;
Luo, Guanhong ;
Liao, Xiaofei ;
Jiang, Wei .
STRAHLENTHERAPIE UND ONKOLOGIE, 2024, 200 (10) :867-875
[47]   Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma: Penang General Hospital Experience [J].
Phua, Chee Ee ;
Tan, Boon Seang ;
Tan, Ai Lian ;
Eng, Kae Yann ;
Ng, Bong Seng ;
Malik, Rozita Abdul ;
Ishak, Wan Zamaniah Wan .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (07) :3287-3292
[48]   Comparison of treatment plans involving intensity-modulated radiotherapy for nasopharyngeal carcinoma [J].
Xia, P ;
Fu, KK ;
Wong, GW ;
Akazawa, C ;
Verhey, LJ .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 48 (02) :329-337
[49]   Analysis of Clinical Target Volume Delineation in Local-regional Failure of Nasopharyngeal Carcinoma after Intensity-modulated Radiotherapy [J].
Yang, Xiaojing ;
Ren, Hanru ;
Yu, Weiwei ;
Zhang, Xiulong ;
Sun, Yi ;
Shao, Yuhui ;
Zhang, Lihua ;
Li, Hongling ;
Yang, Xinmiao ;
Fu, Jie .
JOURNAL OF CANCER, 2020, 11 (07) :1968-1975
[50]   Target volume and position variations during intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma [J].
Tan, Wenyong ;
Li, Yanping ;
Han, Guang ;
Xu, Jiaozhen ;
Wang, Xiaohong ;
Li, Ying ;
Hu, Desheng .
ONCOTARGETS AND THERAPY, 2013, 6 :1719-1728